Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Flavia Saraiva, the Brazilian Olympic gymnast who went viral after her Tinder bio was discovered, showed off a wild workout to improve her flexibility. Aug 1, 2024; Paris, France; Flavia Saraiva ...

Merck faces significant challenges, including increased competition and regulatory scrutiny for Keytruda. Keytruda is facing potential threats from competitors like Summit Therapeutics ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

Olympic gymnast Flavia Saraiva has gone viral for two completely different reasons this past month - and one of them has to do with her 'Tinder account'. On July 30, the Brazilian athlete first went ...

Brazilian bronze medallist Flavia Saraiva added a new twist to her routine and sent hearts leaping – by going on Tinder. Fans raved after spotting her profile on the free dating app. The 24-year ...

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

RAHWAY, N.J., August 29, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided updates on two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630.

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab Clinical ...